Previous close | 24.30 |
Open | 24.24 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 1000 |
Day's range | 24.08 - 24.35 |
52-week range | 16.63 - 26.16 |
Volume | |
Avg. volume | 5,489,042 |
Market cap | 16.368B |
Beta (5Y monthly) | 1.37 |
PE ratio (TTM) | 51.28 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2024 financial results before the market opens on Friday, April 26, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results.
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, recognized supplier excellence across a range of categories and products at its 2024 European Sales Conference in Lisbon, Portugal earlier this month. The event brought together Avantor's European sales organization and the Company's supplier partners and focused on collaboration to deliver an exceptional customer experience.
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston on Tuesday, March 5, 2024, at approximately 10:30 a.m. Eastern Standard Time.